Highlights of Changes in Preferred Drug List (PDL) effective July 2013
Fosinopril, quinapril, and quinapril/hydrochlorothiazide are switching from preferred to non-preferred status.
Antibiotics, Gastrointestinal (GI)
New class of drugs on the PDL. Preferred agents are: Alinia suspension (but only for children
< 18 years old), metronidazole tablets, neomycin, and Vancocin (vancomycin) capsules.
Eliquis (for non-valvular atrial fibrillation) and Pradaxa (for non-valvular atrial fibrillation) are now preferred agents. Xarelto is a preferred agent for the following diagnoses: non-valvular atrial fibrillation, s/p knee or hip replacement (for one fill), and treatment of DVT or PE.
Rizatriptan ODT tablets (generic Maxalt MLT) will be a preferred agent for children ages 6-12 years only. All rizatriptan products remain non-preferred for adults and children > 13 years old.
Brand name Toprol XL is now a preferred agent.
H Pylori Treatment
New class of drugs on the PDL. Preferred agents are Prevpac and Helidac. The non-preferred agents are Pylera and Omeclamox-Pak.